Literature DB >> 1056006

Third component of complement (C3): structural properties in relation to functions.

V A Bokisch, M P Dierich, H J Mūller-Eberhard.   

Abstract

The third component of complement (C3) fulfills a pivotal role in the functions of the complement system. We have investigated the topological relationships among its polypeptide chains, physiologic fragments, enzyme attack regions, and functional sites. C3 consists of two chains (alpha and beta) which are linked by disulfide bonds and noncovalent forces and which have molecular weights of, respectively, 120,000 and 75,000. C3 is activated by action of C3 convertase on the alpha-chain. With hydrolysis of one polypeptide bonds, C3a, the 9000 dalton activation peptide is dislocated from the NH2-terminal portion of the alpha-chain. A previously concealed binding region is thereby transiently revealed in the C3b-fragment (181,000 dalton) which displays affinity for apparently nonspecific acceptors present on biological membranes. Binding of nascent C3b membranes occurs through the C3d portion of the fragment because subsequent action of the C3b-inactivator or trypsin on bound C3b causes release of C3c, but not of C3d. Bound C3b and C3d possess stable sites that are capable of binding to specific receptors present on a limited variety of cells. We propose that all known physiologically occurring fragments of C3 arise by enzymatic cleavage of the alpha-chain: C3a, C3b, C3c, and C3d. Whereas C3a (alpha1) and C3e (alpha2) consist of a single chain and C3b consists of two chains (alpha' and beta), C3c is composed of the entire beta-chain and multiple fragments of the alpha-chain, each of which is linked by disulfide bonds to the beta-chain.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1056006      PMCID: PMC432677          DOI: 10.1073/pnas.72.6.1989

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Antigenic determinants of human beta-1c and beta-1g-globulins.

Authors:  C West; N C Davis; J Forristal; J Herbst; R Spitzer
Journal:  J Immunol       Date:  1966-04       Impact factor: 5.422

2.  Homozygous deficiency of C3 in a patient with repeated infections.

Authors:  C A Alper; H R Colten; F S Rosen; A R Rabson; G M Macnab; J S Gear
Journal:  Lancet       Date:  1972-12-02       Impact factor: 79.321

3.  C3b inactivator of man. II. Fragments produced by C3b inactivator cleavage of cell-bound or fluid phase C3b.

Authors:  S Ruddy; K F Austen
Journal:  J Immunol       Date:  1971-09       Impact factor: 5.422

4.  Purification and partial characterization of human and porcine C3a anaphylatoxin.

Authors:  T E Hugli; E H Vallota; H J Müller-Eberhard
Journal:  J Biol Chem       Date:  1975-02-25       Impact factor: 5.157

5.  Cutaneous responses to human C 3 anaphylatoxin in man.

Authors:  K D Wuepper; V A Bokisch; H J Müller-Eberhard; R B Stoughton
Journal:  Clin Exp Immunol       Date:  1972-05       Impact factor: 4.330

6.  Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase.

Authors:  V A Bokisch; H J Müller-Eberhard
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

7.  The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement.

Authors:  C G Cochrane; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1968-02-01       Impact factor: 14.307

8.  Receptor for soluble C3 and C3b on human lymphoblastoid (RAJI) cells. Properties and biologocal significance.

Authors:  A N Theofilopoulos; V A Bokisch; F J Dixon
Journal:  J Exp Med       Date:  1974-03-01       Impact factor: 14.307

9.  C3 proactivator convertase and its mode of action.

Authors:  H J Müller-Eberhard; O Götze
Journal:  J Exp Med       Date:  1972-04-01       Impact factor: 14.307

10.  The reaction mechanism of beta-1C-globulin (C'3) in immune hemolysis.

Authors:  H J Müllerèberhard; A P Dalmasso; M A Calcott
Journal:  J Exp Med       Date:  1966-01-01       Impact factor: 14.307

View more
  39 in total

1.  Characterization of a C3-like cDNA in a coral: phylogenetic implications.

Authors:  Larry J Dishaw; Sylvia L Smith; Charles H Bigger
Journal:  Immunogenetics       Date:  2005-09-29       Impact factor: 2.846

2.  Induction of complement C3a receptor responses by kallikrein-related peptidase 14.

Authors:  Katerina Oikonomopoulou; Robert A DeAngelis; Hui Chen; Eleftherios P Diamandis; Morley D Hollenberg; Daniel Ricklin; John D Lambris
Journal:  J Immunol       Date:  2013-09-06       Impact factor: 5.422

3.  Cis- and trans-acting elements required for constitutive and cytokine-regulated expression of the mouse complement C3 gene.

Authors:  N Kawamura; L Singer; R A Wetsel; H R Colten
Journal:  Biochem J       Date:  1992-05-01       Impact factor: 3.857

4.  Complement bridges between cells analysis of a possible cell-cell interaction mechanism.

Authors:  M P Dierich; B Landen
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

5.  Biosynthesis and secretion of the third component of complement by human endothelial cells in vitro.

Authors:  A Ueki; T Sai; H Oka; M Tabata; K Hosokawa; Y Mochizuki
Journal:  Immunology       Date:  1987-05       Impact factor: 7.397

6.  Quantification of antibodies to the C3d subcomponent of human C3.

Authors:  H Chaplin; J Freedman; N C Hughes-Jones
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

Review 7.  Anaphylatoxins: their role in bacterial infection and inflammation.

Authors:  Pieter-Jan Haas; Jos van Strijp
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

8.  Immunological studies of human placentae: complement components in pre-eclamptic chorionic villi.

Authors:  D Sinha; M Wells; W P Faulk
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

9.  Non-enzymic activation of the covalent binding reaction of the complement protein C3.

Authors:  S K Law
Journal:  Biochem J       Date:  1983-05-01       Impact factor: 3.857

10.  Endotoxaemia and complement activation in acute pancreatitis in man.

Authors:  A K Foulis; W R Murray; D Galloway; A C McCartney; E Lang; J Veitch; K Whaley
Journal:  Gut       Date:  1982-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.